White Paper
Prescription Opioid Use and Medications to Treat Opioid Use Disorder in North Carolina Medicaid: 2013–2018
Aaron McKethan, PhD, Hilary Campbell, PharmD, JD, Chris Bush, MPH, Melissa A. Greiner, MS, Anna Hung, PharmD, PhD, MS, Andrew Olson, MPP, Jennifer Grant, MPH, Bradley Hammill, DrPH, Marisa Elena Domino, PhD, Jason Rotter, PhD, Alex Gertner, Maggie Holly
2019
Read MoreWhite Paper
Determining Real-World Data’s Fitness for Use and the Role of Reliability
Nirosha Mahendraratnam, Christina Silcox, Kerra Mercon, Adam Kroetsch, Morgan Romine, Nicholas R. Harrison, Adam Aten, Rachel Sherman, Gregory Daniel, Mark McClellan
2019
Read MoreWhite Paper
Measurement For Value-based Payment: Harnessing Patient-Centered Outcomes to Define Quality
Aparna Higgins, Mark B. McClellan, MD, PhD, Dana Gelb Safran, Sc.D., Nick Fiore, Elizabeth Murphy
2019
Read MoreWhite Paper
A Framework for Evaluating the Impact of Prescription Drug Postmarketing Safety Labeling Changes
Mark McClellan, Gregory Daniel, Sarah Sheehan, Morgan Romine, Elizabeth Richardson, Jessica Burnell, Meredith Freed, Becky Briesacher, Stacie Dusetzina, Chester Good, Kenneth Hornbuckle, Joseph Ross
2019
Read More
Decision support tools are valuable, but only if consumers understand them and if they are accurate.
— Charlene Wong, MD, MSHP